CLINICAL_TRIALS
trial_result
· 2023-01-04
Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19 [Phase 2]
Summary
Phase 2 clinical trial evaluating the efficacy and safety of leronlimab for mild to moderate COVID-19 has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: CytoDyn, Inc. | Conditions: Coronavirus Disease 2019 | Phase 2 | Status: COMPLETED | Results posted: 2023-01-04